» Articles » PMID: 28646536

Spectrum of Mutations in Cystinuria Patients Presenting with Prenatal Hyperechoic Colon

Overview
Journal Clin Genet
Specialty Genetics
Date 2017 Jun 25
PMID 28646536
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9. Antenatal hyperechoic colon (HEC) has been reported in some patients as a non-pathological consequence of the intestinal transport defect. We report 83 patients affected by cystinuria: 44 presented prenatally with a HEC (HEC group) and 39 with a classical postnatal form (CC group). SLC3A1 and SLC7A9 were sequenced. All patients were fully genotyped, and the relationship between the genotype and clinical features was analyzed. We identified mutations in SLC3A1 in 80% of the HEC group and in only 49% of the CC group. The SLC3A1 p.Thr216Met mutation was found in 21% of the alleles in the HEC group but was never found in the CC group. Most of the mutations found in the HEC group were considered severe mutations in contrast with the CC group. Twenty-five novel mutations were reported. This study shows a relationship between genotype and the clinical form of cystinuria, suggesting that only the patients with the most severe mutations presented with an HEC. These results emphasized the need for prenatal cystinuria screening using classical third-trimester ultrasound scan and the early management of suspected newborns.

Citing Articles

Prenatal diagnosis of cystinuria with a heterozygous pathogenic variant in gene associated with isolated hyperechogenic fetal kidneys: A case report.

Aigbogun O, Vancoppenolle N, Coppens S, Marangoni M, Elsen E, Cassart M Clin Case Rep. 2024; 12(7):e8730.

PMID: 39015212 PMC: 11250157. DOI: 10.1002/ccr3.8730.


Reversed cortico-medullary differentiation in the fetal and neonatal kidneys: an indicator of poor prognosis?.

Cassart M, Garel C, Ulinski T, Freddy Avni E Pediatr Radiol. 2023; 54(2):285-292.

PMID: 38150104 DOI: 10.1007/s00247-023-05833-0.


Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability.

Lee B, Lee S, Han D, Park H Urolithiasis. 2023; 51(1):94.

PMID: 37439839 PMC: 10345071. DOI: 10.1007/s00240-023-01466-y.


Phenotypic characterization of a pediatric cohort with cystinuria and usefulness of newborn screening.

Pinero-Fernandez J, Vicente-Calderon C, Lorente-Sanchez M, Juan-Fita M, Egea-Mellado J, Gonzalez-Gallego I Pediatr Nephrol. 2022; 38(5):1513-1521.

PMID: 36227436 DOI: 10.1007/s00467-022-05732-w.


Cystinuria: An Overview of Diagnosis and Medical Management.

Sadiq S, Cil O Turk Arch Pediatr. 2022; 57(4):377-384.

PMID: 35822468 PMC: 9317473. DOI: 10.5152/TurkArchPediatr.2022.22105.